Deciphex is delighted to announce its recognition at the Irish Medtech Awards 2023. The Irish Medtech Association, in partnership with Enterprise Ireland and IDA Ireland, recognised Deciphex with not one but two prestigious awards: the coveted Medtech Company of the Year and the Digital Health Innovation of the Year.  These awards underscore the impact of our work in advancing healthcare through technology, innovation, and a commitment to making a positive difference in the lives of patients globally.

At Deciphex, we look forward to a future where our innovations continue to transform healthcare. We are immensely grateful to the Irish Medtech Association, Enterprise Ireland, and IDA Ireland for their recognition and support. Together, we are driving change in the medical technology industry, and these awards reaffirm our mission to make healthcare accessible, efficient, and patient-centric.  As we move forward, we remain dedicated to pushing the boundaries of what is possible in the field of digital health and medical technology. Thank you for being a part of our journey as we redefine the future of healthcare.

Awards Reflecting Innovation and Dedication

Dr. Eoghan Ó Faoláin, Director of the Irish Medtech Association, expressed his delight by saying

"I am happy to recognize Deciphex as the Medtech Company of the Year 2023 in recognition of their work redefining the future of pathology with its fully digital remote expert subspeciality pathology service that enables remote access to experts, eliminates the need for physical samples to be transported miles for diagnoses, and dramatically reducing wait times. Not only is benefiting patients in Europe, it’s also addressing global healthcare disparities in low and Low Middle-Income Countries, such as Trinidad and Tobago and Kenya."

Digital Health Innovation Paving the Way

Ciara Finlay, Senior Executive of the Irish Medtech Association, added to our accolades by announcing Deciphex as the winner of the Digital Health Innovation of the Year Award.

“This recognition is a testament to the impact of our 'Diagnexia' platform, which offers a regulated solution to address the shortage of pathology subspecialty experts. By connecting laboratories worldwide and enabling efficient triaging of colorectal cases, our platform contributes significantly to the efficiency and accuracy of healthcare diagnostics.”

Donal O'Shea, CEO of Deciphex: A Vision of Transformation

Our CEO, Donal O'Shea, emphasised our unwavering commitment to democratising access to high-quality pathology services on a global scale. He stated,

"We are dedicated to democratising access to high-quality pathology services globally. Our innovative platforms, Patholytix and Diagnexia, leverage advanced technology and AI to bridge gaps in healthcare accessibility. Being a finalist for the Irish Medtech Awards' Company of the Year recognizes our commitment to enhancing healthcare through digital innovation. Winning this award would affirm our role in transforming pathology services, ensuring broader and more equitable access to essential diagnostics, and ultimately improving patient care worldwide."

Read more here: https://www.med-technews.com/news/medtech-ireland/winners-of-irish-medtech-awards-2023-announced/